The levels of the transcription factors, STAT1 and STAT3 (which are associated with cisplatin-induced hearing loss) showed differential regulation, with the levels of STAT1 showing peak increases in 12 h, which diminished over 72 h. Here, STAT1 is linked to hearing loss disorder.